Susceptibility to Cell Death Is a Dominant Phenotype: Triggering of Activation-Driven T-Cell Death Independent of the T-Cell Antigen Receptor Complex

References

• Ashwell, J. D., R. E. Cunningham, P. D. Noguchi, and D. Hernandez. 1987. Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 165:173–194.
   PubMed Web of Science ®Google Scholar
• Bamezai, A., H. Reiser, and K. L. Rock. 1988. T cell receptor/ CD3 negative variants are unresponsive to stimulation through the Ly-6 encoded molecule, TAP. J. Immunol. 141:1423–1428.
   PubMedGoogle Scholar
• Chen, S., F. Botteri, H. Van Der Putten, C. P. Landel, and G. A. Evans. 1987. A lymphoproliferative abnormality associated with inappropriate expression of the Thy-1 antigen in transgenic mice. Cell 51:7–19.
   PubMedGoogle Scholar
• Emmel, E. A., C. L. Verweij, D. B. Durand, K. M. Higgins, E. Lacy, and G. R. Crabtree. 1989. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 246:1617–1620.
   PubMed Web of Science ®Google Scholar
• Ferrick, D. A., B. Sydora, V. Wallace, L. Gemmell-Hori, M. Kronenberg, and T. W. Mak. 1991. Self-reactive γδ T lymphocytes: implications for T-cell ontogeny and reactivity. Immunol. Rev. 120:51–69.
   PubMedGoogle Scholar
• Finkel, T. H., J. C. Cambier, R. T. Kubo, W. K. Born, P. Marrack, and J. W. Kappler. 1989. The thymus has two functionally distinct populations of immature αβ+ T cells: one population is deleted by ligation of αβTCR. Cell 58:1047–1054.
   PubMedGoogle Scholar
• Fowlkes, B. J., R. H. Schwartz, and D. M. Pardoll. 1988. Deletion of self-reactive thymocytes occurs at a CD4+8+ precursor stage. Nature (London) 334:620–623.
   PubMed Web of Science ®Google Scholar
• Gao, E.-K., D. Lo, R. Cheney, O. Kanagawa, and J. Sprent. 1988. Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature (London) 336:176–179.
   PubMed Web of Science ®Google Scholar
• Gunter, K. C., R. N. Germain, R. A. Kroczek, T. Saito, W. M. Yokoyama, C. Chan, A. Weiss, and E. M. Shevach. 1987. Thy-l-mediated T-cell activation requires co-expression of CD3/Ti complex. Nature (London) 326:505–507.
   PubMedGoogle Scholar
• Gunter, K. C., T. R. Malek, and E. M. Shevach. 1984. T cell-activating properties of an anti-Thy-1 monoclonal antibody: possible analogy to OKT3/LEU-4. J. Exp. Med. 159:716–730.
   PubMed Web of Science ®Google Scholar
• Hsi, E. D., J. N. Siegel, Y. Minami, E. T. Luong, R. D. Klausner, and L. E. Samelson. 1989. T cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates. J. Biol. Chem. 264:10836–10842.
   PubMedGoogle Scholar
• Jenkins, M. K., R. H. Schwartz, and D. M. Pardoll. 1988. Effects of cyclosporine A on T cell development and clonal deletion. Science 241:1655–1658.
   PubMed Web of Science ®Google Scholar
• Kisielow, P., H. Bluthmann, U. D. Staerz, M. Steinmetz, and H. von Boehmer. 1988. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature (London) 333:742–746.
   PubMed Web of Science ®Google Scholar
• Kollias, G., D. J. Evans, M. Ritter, J. Beech, R. Morris, and F. Grosveld. 1987. Ectopic expression of Thy-1 in the kidneys of transgenic mice induces functional and proliferative abnormalities. Cell 51:21–31.
   PubMedGoogle Scholar
• Kroczek, R. A., K. G. Gunter, R. N. Germain, and E. M. Shevach. 1986. Thy-1 functions as a signal transduction molecule in T lymphocytes and transfected B lymphocytes. Nature (London) 322:181–184.
   PubMed Web of Science ®Google Scholar
• Kruisbeek, A. Personal communication.
   Google Scholar
• Ledbetter, J. A., and L. A. Herzenberg. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63–90.
   PubMed Web of Science ®Google Scholar
• Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374–1378.
   PubMed Web of Science ®Google Scholar
• Marusic-Galesic, S., D. M. Pardoll, T. Saito, O. Leo, B. J. Fowlkes, J. Coligan, R. N. Germain, R. H. Schwartz, and A. M. Kruisbeek. 1988. Activation properties of T cell receptor-γδ hybridomas expressing diversity in both γ-and δ-chains. J. Immunol. 140:411–418.
   PubMed Web of Science ®Google Scholar
• McConkey, D. J., P. Hartzell, J. F. Amador-Perez, S. Orrenius, and M. Jondal. 1989. Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J. Immunol. 143:1801–1806.
   PubMed Web of Science ®Google Scholar
• Mercep, M., J. A. Bluestone, P. D. Noguchi, and J. D. Ashwell. 1987. Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules. J. Immunol. 140:324–335.
   Google Scholar
• Mercep, M., P. D. Noguchi, and J. D. Ashwell. 1989. The cell cycle block and lysis of an activated T cell hybridoma are distinct processes with different Ca2+ requirements and sensitivity to cyclosporine A. J. Immunol. 142:4085–4092.
   PubMed Web of Science ®Google Scholar
• Muller-Sieburg, C. E., C. A. Whitlock, and I. L. Weissman. 1986. Isolation of two early B lymphocyte progenitors from mouse marrow: a committed pre-pre-B cell and a clonogenic Thy-1lo hematopoietic stem cell. Cell 44:653–662.
   PubMed Web of Science ®Google Scholar
• Odaka, C., H. Kizaki, and T. Tadakuma. 1990. T cell receptor- mediated DNA fragmentation and cell death in T cell hybridomas. J. Immunol. 144:2096–2101.
   PubMed Web of Science ®Google Scholar
• Ralph, P. 1973. Retention of lymphocyte characteristics by myelomas and θ+-lymphomas: sensitivity to cortisol and phytohemagglutinin. J. Immunol. 110:1470–1474.
   PubMed Web of Science ®Google Scholar
• Schmitt-Verhulst, A.-M., A. Guimezanes, C. Boyer, M. Poenie, R. Tsien, M. Buferne, C. Hua, and L. Leserman. 1987. Pleio- tropic loss of activation pathways in a T-cell receptor α-chain deletion variant of a cytolytic T-cell clone. Nature (London) 325:628–631.
   PubMedGoogle Scholar
• Shi, Y., B. M. Sahai, and D. R. Green. 1989. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature (London) 339:625–626.
   PubMed Web of Science ®Google Scholar
• Smith, C. A., G. T. Williams, R. Kingston, E. J. Jenkinson, and J. J. T. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (London) 337:181–184.
   PubMed Web of Science ®Google Scholar
• Sussman, J. J., M. Mercep, T. Saito, R. N. Germain, E. Bonvini, and J. D. Ashwell. 1988. Dissociation of phosphoinositide hydrolysis and Ca2+ fluxes from the biological responses of a T-cell hybridoma. Nature (London) 334:625–628.
   PubMed Web of Science ®Google Scholar
• Sussman, J. J., T. Saito, E. M. Shevach, R. N. Germain, and J. D. Ashwell. 1988. Thy-1- and Ly-6-mediated lymphokine production and growth inhibition of a T cell hybridoma require co-expression of the T cell antigen receptor complex. J. Immunol. 140:2520–2526.
   PubMed Web of Science ®Google Scholar
• Tadakuma, T., H. Kizaki, C. Odaka, R. Kubota, Y. Ishimura, H. Yagita, and K. Okumura. 1990. CD4+8+ thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody. Eur. J. Immunol. 20:779–784.
   PubMedGoogle Scholar
• Truneh, A., F. Albert, P. Golstein, and A.-M. Schmitt-Verhulst. 1985. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature (London) 313:318–320.
   PubMed Web of Science ®Google Scholar
• Ucker, D. S. 1991. Death by suicide: one way to go in mammalian cellular development? New Biol. 3:103–109.
   PubMedGoogle Scholar
• Ucker, D. S., J. D. Ashwell, and G. Nickas. 1989. Activation- driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation. J. Immunol. 143:3461–3469.
   PubMed Web of Science ®Google Scholar
• Ucker, D. S., J. Meyers, A. Glasebrook, and P. S. Obermiller. Submitted for publication.
   Google Scholar
• White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D. P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143:1822–1825.
   PubMed Web of Science ®Google Scholar
• Zacharchuk, C. M., M. Mercep, P. K. Chakraborti, S. S. Simons, Jr., and J. D. Ashwell. 1990. Programmed T lymphocyte death: cell activation- and steroid-induced pathways are mutually antagonistic. J. Immunol. 145:4037–4045.
   PubMed Web of Science ®Google Scholar